Skip to content
Screener

Harrow HROW Finite-Lived Intangible Assets, Accumulated Amortization

Finite-Lived Intangible Assets, Accumulated Amortization at other companies

Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS
$2.12M+83.3%
AbbVie logo
AbbVieABBV
Bausch + Lomb logo
Bausch + LombBLCO
Bausch Health Companies logo
Bausch Health CompaniesBHC
PTH
Pelthos TherapeuticsPTHS
TOI
TOITOI

Other financials

Income statement

See full
Revenue$70.7M+10.9%
Gross profit$50.4M+6.0%
Operating income-$11.0M-196%
Net income-$17.3M-446%
EPS (diluted)-$0.46-454%

Balance sheet

See full
Cash & equivalents$83.9M+58.4%
Total debt$308.4M-32.0%
Total equity$15.2M-69.4%
Total assets$416.8M+20.8%

Cash flow

See full
Operating cash flow-$9.8M
CapEx$491.0K+196%
Free cash flow-$10.2M

Valuation

See full
Market cap$1.51B+21.7%
Enterprise value$1.73B+5.7%
P/S5.5×0.0×

Profitability

See full
Gross margin73.3%-1.3pp
Operating margin-1%-7.3pp
Net margin-19.8%+18.0pp
FCF margin1.8%+1.3pp

Returns & leverage

See full
Return on equity-50%+17.5pp
Debt / equity20.3×+11.2×
Current ratio2.2×+1.6×

Where this comes from

Reported directly by Harrow in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization.

The source filing: Harrow’s 10-Q, filed August 10, 2026.

Filed
Aug 10, 2026, 4:28 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-055271
Line itemWeighted-average useful life(in years)CostAccumulated AmortizationNet Carrying Value
Licenses2050,000(40,000)10,000
Acquired product rights14225,481,000(50,552,000)174,929,000
Customer relationships7190,000(155,000)35,000
Trade name570,000(4,000)66,000
State pharmacy licenses258,000(4,000)4,000
Indefinite-lived Intangibles
TrademarksIndefinite340,000340,000
$226,408,000$(50,838,000)$175,570,000

Item 1. Financial Statements

FAQ

What is Harrow's finite-lived intangible assets, accumulated amortization?
Harrow (HROW) reported finite-lived intangible assets, accumulated amortization of $50.84M in Q2 2026.
How has Harrow's finite-lived intangible assets, accumulated amortization changed year-over-year?
Harrow's finite-lived intangible assets, accumulated amortization increased by 258.6% year-over-year, from -$32.06M to $50.84M.
What is the long-term trend for Harrow's finite-lived intangible assets, accumulated amortization?
Over 5 years (2020 to 2025), Harrow's finite-lived intangible assets, accumulated amortization has grown at a 130.7% compound annual growth rate (CAGR), from -$615K to -$40.18M.
What does finite-lived intangible assets, accumulated amortization mean?
Finite-Lived Intangible Assets, Accumulated Amortization

Ask your AI about Harrow's finite-lived intangible assets, accumulated amortization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude